| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |